Published in Medical Letter on the CDC and FDA, August 29th, 2004
The generic drugs, which are manufactured by India's Ranbaxy Laboratories, will be kept off the World Health Organization's list of approved HIV treatments until the company can submit evidence of new tests that prove the drugs are biologically equivalent to the original medicines, the agency said in a statement.
"This effectively means that the medicines may or may not offer the same therapeutic benefits as the originals on which they are...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.